PALANTIR TECH INC

Data analytics company Palantir Technologies Inc was awarded a $44.4 million contract by the U.S. Food and Drug Administration, a Palantir spokeswoman said, sending its shares up around 21%. More
Palantir Technologies (NYSE: PLTR) shares have been on a wild ride of late, up 50% for the week and 170% for the month. The software and data tech company got off to a hot start Friday morning, gaining as much as 15%, but then plunged after a prominent short-seller issued a warning about the stock. The shares are now up more than 200% since its debut, with investors optimistic that Palantir’s sophisticated data analysis tools will continue to gain traction with government and commercial customers. More
The company is projecting 2020 revenue to grow around 42% and 2021 revenue to grow more than 30%. It had a net loss of nearly $600 million in 2019. More
The rush to the public markets comes as the economic downturn caused by the pandemic has led some companies to rethink their capital needs. More
The company flexes its muscle, winning business at home and abroad. More